Status:
RECRUITING
PuraStat® Combined With Adrenaline Versus Standard of Care in Upper Gastrointestinal Bleeding
Lead Sponsor:
Tallaght University Hospital
Conditions:
Upper Gastrointestinal Bleeding
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
PuraStat® is a novel gel that offers several advantages over traditional hemostatic powders. Its transparency allows for continuous visualization of the bleeding site, and it can be applied in narrow ...
Detailed Description
Endoscopic treatment serves as the first-line approach in managing upper gastrointestinal bleeding (UGIB), demonstrating effectiveness in reducing re-bleeding rates, the need for surgical intervention...
Eligibility Criteria
Inclusion
- Age \>18 years
- Undergoing endoscopic therapy for non-variceal gastrointestinal bleeding
Exclusion
- Variceal or portal hypertension-related gastrointestinal bleeding
- Lack of signed consent form
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06896409
Start Date
October 1 2023
End Date
October 1 2025
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Arnau de Vilanova de Lleida
Lleida, Spain